News Around World

Clinical trials in Africa receive funding boost

€80 million will be injected into African medical research, according to the European and Developing Countries Clinical Trials Partnership. Among the allocations from the amount, half of it would be provided for malaria research and the development of TB vaccines, while the remnants are to be expedited for HIV and TB treatments and for vaccines and microbicides. The projects are to empower Africans by enabling them to take ownership of their own projects.

A new study suggests that the conventional view, which assumes that cells are "instructed" to progress along prescribed signaling pathways, is too simplistic. Instead, it supports the idea that cells differentiate through the collective behavior of multiple genes in a network that ultimately leads to just a few endpoints -- just as a marble on a hilltop can travel a nearly infinite number of downward paths, only to arrive in the same valley. The findings, published in the May 22 issue of Nature, help explain why the process of differentiating stem cells into specific lineages in the laboratory has been highly inefficient.

A protein in plants that could help to reduce the toxic content of crops grown in environments with high levels of arsenic has been discovered. Arsenic is acutely toxic and a highly potent carcinogen, but is widespread in the earth's crust and easily taken up and accumulated in crops. A team of Scandinavian researchers has revealed a set of plant proteins that channel arsenic in and out of cells.